GWCM
AMGN icon

Godshalk Welsh Capital Management’s Amgen AMGN Stock Holding History

Godshalk Welsh Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$452K Hold
1,285
– – 0.26% 92
2025
Q4 		$421K Buy
1,285
+50
+4% +$15.9K 0.24% 90
2025
Q3 		$349K Hold
1,235
– – 0.2% 101
2025
Q2 		$345K Buy
1,235
+40
+3% +$11.3K 0.21% 102
2025
Q1 		$372K Buy
1,195
+25
+2% +$7.38K 0.24% 93
2024
Q4 		$305K Buy
1,170
+25
+2% +$7.42K 0.2% 100
2024
Q3 		$369K Buy
1,145
+150
+15% +$49.1K 0.23% 94
2024
Q2 		$311K Buy
995
+125
+14% +$36.7K 0.21% 97
2024
Q1 		$247K Buy
870
+155
+22% +$45.4K 0.17% 112
2023
Q4 		$206K Buy
+715
New +$195K 0.15% 116
2015
Q1 		– Sell
-600
Closed -$96K – 138
2014
Q4 		$96K Buy
+600
New +$93.5K 0.09% 168

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Godshalk Welsh Capital Management's AMGN Position: Q1 2026 in Review

Godshalk Welsh Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 1,285 shares worth $452K. The position accounts for 0.26% of the portfolio, ranked #92.

Godshalk Welsh Capital Management first reported a position in AMGN in Q4 2014 and has held it in 11 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Godshalk Welsh Capital Management held 1,285 shares of Amgen worth $452K as of Q1 2026.
  • Godshalk Welsh Capital Management left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.26% of Godshalk Welsh Capital Management's portfolio in Q1 2026, its #92 holding.
  • Godshalk Welsh Capital Management first reported a position in Amgen in Q4 2014 and has held it in 11 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Godshalk Welsh Capital Management's 13F filing for Q1 2026, filed 13 May 2026.